companydata.dkcompanydata.dk

LGC Biosearch Technologies A/S: Financial statements 2025

CVR: 34884900

Source: annual report 2025, Danish Business Authority

01/04/2024 – 31/03/2025

LGC Biosearch Technologies A/S (CVR 34884900) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 114,534,327 and a net result of DKK 11,805,577 compared with DKK 2,559,303 the year before. That is an increase of 8.5% compared with the year before. The profit margin was 10.3%. Equity in the 2025 report amounted to DKK 91,679,575. The solvency ratio was 82.6%. The company had 51 employees in the financial year.

Revenue
DKK 114,534,327
Gross Profit
DKK 58,863,278
Profit/Loss
DKK 11,805,577
Equity
DKK 91,679,575
Total Assets
DKK 110,995,799
Employees
51

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025114.5M58.9M11.8M91.7M51
2024105.6M46.3M2.6M79.9M54
2023118M60.1M11.7M77.3M29
2022101.5M50.5M12.6M65.6M22
2021103.8M70.9M35.6M53M29

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LGC Biosearch Technologies A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About LGC Biosearch Technologies A/S

LGC Biosearch Technologies A/S is a Danish company of the type Aktieselskab based in Lystrup, founded in 2012. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named DNA TECHNOLOGY A/S and BIOSEARCH TECHNOLOGIES DENMARK A/S. The management consists of Daren Dick. The board consists of Henrik Daugård (chair), Bettina Kecskes and Daren Dick. The company is owned by Biosearch Technologies, Inc.. The company has 47 employees (2026). In 2026, the company reported revenue of DKK 106,677,751 and a net result of DKK 8,198,725 compared with DKK 11,805,577 the year before. Equity in the 2026 report amounted to DKK 88,072,722.

Source: annual report 2026, Danish Business Authority